SQN are celebrating being named as winners of a Queen’s Award forInnovation – the UK’s highest accolade for business success – for Syne-clin, our innovative EDC and Trial Management system.
This is a significant recognition for us and all of our staff and supports the outstanding international reputation that we have as one of the world’s premier clinical biometrics service providers.
SQN was previously awarded a Queen’s Award for Enterprise in 2009, in the international trade category in recognition of our business growth and export performance. So this award is doubly significant.
Tony Rees, SQN Director, commenting on the award said, “We are extremely proud and honoured to have received this prestigious Award. This recognises the achievements of our dedicated team of staff and SQN’s commitment to innovation, technical development and IT services that help to improve the efficiency of their clinical development process to the ultimate benefit to patients and society generally.”
Example Syne-clin data collection forms and reports used by SQN in supporting clinical trials.
HIGH QUALITY, LOW RISK AND TRUST…IS SIMPLY A CHOICE
SQN is one of the worlds recognised specialist clinical biometrics CROs supporting global pharma, biotech, medical device and animal health partners with innovative, cost effective clinical development services.
Syne qua non and uMotif partner to bring next-generation patient-centric data capture technology to clinical trial sponsors Syne qua non (SQN), the award-winning biometrics CRO have signed a new partnership...